Patil DH - Search Results

1

2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race.

Schmeusser BN, Patil DH, Nicaise EH, Armas-Phan M, Nabavizadeh R, Narayan VM, Joshi SS, Ogan K, Osunkoya AO, Bilen MA, Master VA. Schmeusser BN, et al. Among authors: patil dh. Cancer. 2024 Feb 1;130(3):453-466. doi: 10.1002/cncr.35037. Epub 2023 Oct 6. Cancer. 2024. PMID: 37803521

2

High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis.

Holzman SA, de la Calle CM, Kissick HT, Osunkoya AO, Pollack BP, Patil D, Ogan K, Master VA. Holzman SA, et al. Urol Int. 2015;95(1):72-8. doi: 10.1159/000370164. Epub 2015 Feb 20. Urol Int. 2015. PMID: 25721803

3

Safety and Efficacy of Ureteral Stent Placement at the Bedside Using Local Anesthesia.

Nourparvar P, Leung A, Shrewsberry AB, Weiss AD, Patil D, Atallah H, Ogan K, Carney KJ, Master VA. Nourparvar P, et al. J Urol. 2016 Jun;195(6):1886-90. doi: 10.1016/j.juro.2015.11.083. Epub 2016 Jan 22. J Urol. 2016. PMID: 26804752

4

Renal cell carcinoma with vena caval involvement: a contemporary clinicopathologic analysis of 53 cases.

Nwadei IU, Lorentz A, Patil D, Dimarco MA, Master VA, Osunkoya AO. Nwadei IU, et al. Hum Pathol. 2016 Mar;49:83-9. doi: 10.1016/j.humpath.2015.10.009. Epub 2015 Nov 2. Hum Pathol. 2016. PMID: 26826414

5

Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma.

Broggi MS, Patil D, Baum Y, Nieh PT, Alemozaffar M, Pattaras JG, Ogan K, Master VA. Broggi MS, et al. Urology. 2016 Oct;96:99-105. doi: 10.1016/j.urology.2016.05.064. Epub 2016 Jul 16. Urology. 2016. PMID: 27431662

6

Author Reply.

Broggi MS, Patil D, Baum Y, Nieh PT, Alemozaffar M, Pattaras JG, Ogan K, Master VA. Broggi MS, et al. Urology. 2016 Oct;96:105. doi: 10.1016/j.urology.2016.05.066. Epub 2016 Aug 15. Urology. 2016. PMID: 27539917 No abstract available.

7

Urologist Use of Cystoscopy for Patients Presenting With Hematuria in the United States.

David SA, Patil D, Alemozaffar M, Issa MM, Master VA, Filson CP. David SA, et al. Urology. 2017 Feb;100:20-26. doi: 10.1016/j.urology.2016.09.018. Epub 2016 Sep 16. Urology. 2017. PMID: 27645524

8

Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.

Gerhard RS, Patil D, Liu Y, Ogan K, Alemozaffar M, Jani AB, Kucuk ON, Master VA, Gillespie TW, Filson CP. Gerhard RS, et al. Urol Oncol. 2017 May;35(5):250-256. doi: 10.1016/j.urolonc.2016.12.004. Epub 2017 Jan 12. Urol Oncol. 2017. PMID: 28089387 Free PMC article.

9

Patient Frailty and Discharge Disposition Following Radical Cystectomy.

Pearl JA, Patil D, Filson CP, Arya S, Alemozaffar M, Master VA, Ogan K. Pearl JA, et al. Clin Genitourin Cancer. 2017 Aug;15(4):e615-e621. doi: 10.1016/j.clgc.2016.12.013. Epub 2017 Jan 5. Clin Genitourin Cancer. 2017. PMID: 28139446

10

Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.

Baum YS, Patil D, Huang JH, Spetka S, Torlak M, Nieh PT, Alemozaffar M, Ogan K, Master VA. Baum YS, et al. Asian J Urol. 2016 Jan;3(1):20-25. doi: 10.1016/j.ajur.2015.09.004. Epub 2015 Sep 21. Asian J Urol. 2016. PMID: 29264158 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters